FSD Pharma Inc. HUGE NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

44/100

1/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

FSD Pharma Inc. (HUGE) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 40/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score

44/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

健康

67/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

28/100

→ Income

✓

成长

80/100

→ Income

—

收入

N/A

No coverage

估值概览 — HUGE

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.47

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2015	$-0.01	$0.00	$-32.8K	-
2016	$0.00	$0.00	$-29.63K	-
2017	$-0.43	$20.63K	$-2.8M	-13586%
2018	$-2.82	$65.17K	$-16.67M	-25585.9%
2019	$-5.68	$196.82K	$-40.05M	-20350.3%
2020	$-2.72	$0.00	$-32.72M	-
2021	$-1.01	$0.00	$-35.41M	-
2022	$-0.60	$0.00	$-23.32M	-
2023	$-0.47	$0.00	$-18.56M	-